| Name |
Requip Modutab 2 mg tablete s produljenim oslobađanjem |
| Marketing Authorisation Number |
HR-H-575488109 |
| Active Substance |
ropinirolklorid |
| Composition |
jedna tableta s produljenim oslobađanjem sadrži 2 mg ropinirola u obliku ropinirolklorida |
| Pharmaceutical Form |
tableta s produljenim oslobađanjem |
| Manufacturer |
Glaxo Wellcome S.A., Aranda de Duero, Burgos, Španjolska |
| Marketing Authorisation Holder |
GlaxoSmithKline Trading Services Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24, Irska |
| Marketing Authorisation Date |
20.08.2021 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/18-02/185 |
| Registration Number |
381-12-01/70-21-17 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product on medical prescription for renewable delivery
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
N04BC04 |
| Marketing status |
Marketed |
| Shortage status |
No shortage |
| SmPC |
download |
| PL |
download |
